| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Maree Smith | Q24851696 |
| P2093 | author name string | Nemat Khan | |
| P2860 | cites work | Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling | Q24307989 |
| Recommendations for the pharmacological management of neuropathic pain: an overview and literature update | Q24616897 | ||
| Neurotrophin-regulated signalling pathways | Q24678332 | ||
| Mechanisms of acupuncture-electroacupuncture on persistent pain | Q26866252 | ||
| Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management | Q27011486 | ||
| Neurotrophin signal transduction in the nervous system | Q27876223 | ||
| Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats | Q80605700 | ||
| NT-3 expression in spared DRG and the associated spinal laminae as well as its anterograde transport in sensory neurons following removal of adjacent DRG in cats | Q80821809 | ||
| The role of neurotrophins in the maintenance of the spinal cord motor neurons and the dorsal root ganglia proprioceptive sensory neurons | Q81259421 | ||
| Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury | Q82679670 | ||
| Efficacy and safety of tanezumab in the treatment of chronic low back pain | Q84421146 | ||
| Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats | Q84855400 | ||
| Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system | Q49137091 | ||
| Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. | Q51326054 | ||
| Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). | Q51668434 | ||
| Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment. | Q51707357 | ||
| Introduction of a neurotrophin-3 transgene into muscle selectively rescues proprioceptive neurons in mice lacking endogenous neurotrophin-3. | Q52192540 | ||
| Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. | Q52214955 | ||
| NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. | Q52535261 | ||
| Neurotrophins from dorsal root ganglia trigger allodynia after spinal nerve injury in rats. | Q53747564 | ||
| In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. | Q54104418 | ||
| Role of nerve growth factor-tyrosine kinase receptor A signaling in paclitaxel-induced peripheral neuropathy in rats. | Q54225222 | ||
| Suppression of the p75 neurotrophin receptor in uninjured sensory neurons reduces neuropathic pain after nerve injury. | Q54292334 | ||
| Peripheral and Central Mechanisms of NGF-induced Hyperalgesia | Q56980379 | ||
| Nerve growth factor-induced hyperalgesia in the neonatal and adult rat | Q56980397 | ||
| Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo | Q56990844 | ||
| NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin | Q57215013 | ||
| Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. | Q39417487 | ||
| Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. | Q39598750 | ||
| Proneurotrophins require endocytosis and intracellular proteolysis to induce TrkA activation | Q39647271 | ||
| TrkA receptor "hot spots" for binding of NT-3 as a heterologous ligand | Q40144725 | ||
| NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. | Q40345535 | ||
| Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury | Q40630598 | ||
| Neurotrophin-4, alone or heterodimerized with brain-derived neurotrophic factor, is sorted to the constitutive secretory pathway | Q40635192 | ||
| Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve | Q40762287 | ||
| Developmental changes in NT3 signalling via TrkA and TrkB in embryonic neurons. | Q40789379 | ||
| Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord | Q40903406 | ||
| NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. | Q40914375 | ||
| Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons | Q40958612 | ||
| A role for nerve growth factor in sympathetic sprouting in rat dorsal root ganglia | Q40976134 | ||
| Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain | Q41055368 | ||
| Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation | Q41143334 | ||
| Neurotrophic factors in the treatment of peripheral neuropathy. | Q41159493 | ||
| Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy | Q41197663 | ||
| Neuropathic pain is constitutively suppressed in early life by anti-inflammatory neuroimmune regulation | Q41581503 | ||
| Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB | Q41658559 | ||
| Trk receptors: roles in neuronal signal transduction | Q27919636 | ||
| Sortilin: a receptor to regulate neuronal viability and function | Q28260073 | ||
| Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary | Q28276438 | ||
| Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system | Q28505213 | ||
| Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction | Q28571071 | ||
| Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord | Q28571753 | ||
| Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons | Q31840674 | ||
| The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons | Q33735104 | ||
| Trk receptors: mediators of neurotrophin action | Q33950703 | ||
| Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis | Q34017385 | ||
| Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor | Q34071965 | ||
| Understanding proneurotrophin actions: Recent advances and challenges | Q34100777 | ||
| Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain | Q34224419 | ||
| The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice | Q34245104 | ||
| Central modulation of pain | Q34245455 | ||
| Remyelination in multiple sclerosis: a new role for neurotrophins? | Q34287004 | ||
| Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages | Q34374550 | ||
| Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? | Q34639336 | ||
| Neuropathic pain: redefinition and a grading system for clinical and research purposes | Q34713765 | ||
| Analgesic mechanism of electroacupuncture in a rat L5 spinal nerve ligation model | Q35048774 | ||
| Antagonism of nerve growth factor-TrkA signaling and the relief of pain | Q35064559 | ||
| Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. | Q35184731 | ||
| Induction of nerve growth factor receptor in Schwann cells after axotomy | Q35609990 | ||
| The role of growth factors in diabetic peripheral neuropathy. | Q35661123 | ||
| The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain | Q35669849 | ||
| Interventional management of neuropathic pain: NeuPSIG recommendations | Q35794710 | ||
| Regulation of Neurotrophin-3 and Interleukin-1β and Inhibition of Spinal Glial Activation Contribute to the Analgesic Effect of Electroacupuncture in Chronic Neuropathic Pain States of Rats | Q35805686 | ||
| Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord | Q35822338 | ||
| Plasticity of pain signaling: role of neurotrophic factors exemplified by acid-induced pain. | Q35884832 | ||
| Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. | Q36085707 | ||
| BDNF in sensory neurons and chronic pain | Q36413814 | ||
| Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats | Q36431214 | ||
| Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors | Q36447081 | ||
| Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics follo | Q36476481 | ||
| Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. | Q41664947 | ||
| Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice | Q41665271 | ||
| Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. | Q41715272 | ||
| Injury Induced Activation of Extracellular Signal-Regulated Kinase (ERK) in the Rat Rostral Ventromedial Medulla (RVM) is Age Dependant and Requires the Lamina I Projection Pathway | Q41772718 | ||
| Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve | Q42056826 | ||
| The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw. | Q42078588 | ||
| Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord | Q42439525 | ||
| Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits | Q42444231 | ||
| CB1 cannabinoid receptor agonist prevents NGF-induced sensitization of TRPV1 in sensory neurons | Q42566809 | ||
| Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord. | Q42800909 | ||
| Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation | Q43192659 | ||
| Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies | Q43846708 | ||
| Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia | Q44219073 | ||
| Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. | Q44228549 | ||
| Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice | Q44241806 | ||
| Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia. | Q44324995 | ||
| Neurotrophin‐3 down‐regulates trkA mRNA, NGF high‐affinity binding sites, and associated phenotype in adult DRG neurons | Q44597445 | ||
| Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. | Q45023423 | ||
| Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. | Q45230651 | ||
| Repetitive hyperbaric oxygen treatment attenuates complete Freund's adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord | Q45836278 | ||
| Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord | Q45855288 | ||
| Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee | Q46259879 | ||
| Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons | Q46436184 | ||
| Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway | Q46616468 | ||
| Effects of electroacupuncture on cold allodynia in a rat model of neuropathic pain: mediation by spinal adrenergic and serotonergic receptors | Q46626488 | ||
| Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. | Q46884566 | ||
| Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. | Q47249503 | ||
| Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: colocalization of GAP-43 and CGRP. | Q47364955 | ||
| Contribution of neurotrophin-3 to the neuropeptide Y-induced increase in neurite outgrowth of rat dorsal root ganglion cells | Q47734320 | ||
| BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia. | Q47913541 | ||
| Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties | Q48120803 | ||
| Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia | Q48128408 | ||
| Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro | Q48155718 | ||
| Endogenous TrkB ligands suppress functional mechanosensory plasticity in the deafferented spinal cord | Q48157959 | ||
| Nerve growth factor administration protects against experimental diabetic sensory neuropathy | Q48190313 | ||
| Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. | Q48191303 | ||
| Electroacupuncture attenuates mechanical and warm allodynia through suppression of spinal glial activation in a rat model of neuropathic pain | Q48226606 | ||
| BDNF is involved in sympathetic sprouting in the dorsal root ganglia following peripheral nerve injury in rats. | Q48265811 | ||
| Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients | Q48306926 | ||
| Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats | Q48408629 | ||
| Attenuation of mechanical hyperalgesia following spinal cord injury by administration of antibodies to nerve growth factor in the rat. | Q48420373 | ||
| The effects of NGF and sensory nerve stimulation on collateral sprouting and gene expression in adult sensory neurons | Q48455674 | ||
| Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies | Q48477752 | ||
| Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord | Q48617112 | ||
| Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis | Q48636254 | ||
| Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain | Q48697972 | ||
| Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients. | Q48808347 | ||
| Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons | Q48906291 | ||
| Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice | Q48925048 | ||
| Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis | Q48940708 | ||
| The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC. | Q49062410 | ||
| Regulation of Trk receptors following contusion of the rat spinal cord | Q49067304 | ||
| BDNF: a neuromodulator in nociceptive pathways? | Q57898658 | ||
| ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model | Q57990428 | ||
| Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve | Q59086360 | ||
| Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin | Q60705124 | ||
| Effects of Endogenous Neurotrophins on Sympathetic Sprouting in the Dorsal Root Ganglia and Allodynia Following Spinal Nerve Injury | Q60706886 | ||
| Satellite-cell-derived nerve growth factor and neurotrophin-3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat | Q60706906 | ||
| Intrathecal NGF Administration Reduces Reactive Astrocytosis and Changes Neurotrophin Receptors Expression Pattern in a Rat Model of Neuropathic Pain | Q61071120 | ||
| BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? | Q61709659 | ||
| Neurotrophins giveth and they taketh away | Q64445328 | ||
| Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid | Q67984181 | ||
| Contribution of protein kinase C to central sensitization and persistent pain following tissue injury | Q68014211 | ||
| Nerve growth factor prevents experimental cisplatin neuropathy | Q68068322 | ||
| Nerve growth factor receptors on normal and injured sensory neurons | Q69335214 | ||
| Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats | Q70958208 | ||
| Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy | Q71879369 | ||
| BDNF produces analgesia in the formalin test and modifies neuropeptide levels in rat brain and spinal cord areas associated with nociception | Q71913305 | ||
| trkB-like immunoreactivity in rat dorsal root ganglia following sciatic nerve injury | Q72406959 | ||
| Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats | Q72557687 | ||
| Anatomical evidence supporting the potential for modulation by multiple neurotrophins in the majority of adult lumbar sensory neurons | Q73089927 | ||
| Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group | Q73135923 | ||
| Neurotrophin expression by spinal motoneurons in adult and developing rats | Q73282050 | ||
| Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects | Q73365723 | ||
| Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord | Q73797605 | ||
| Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat | Q73820547 | ||
| Up-regulation of the TrkB receptor in mice injured by the partial ligation of the sciatic nerve | Q74107179 | ||
| Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats | Q74440935 | ||
| Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve | Q74587113 | ||
| Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice | Q77134735 | ||
| Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord | Q77319896 | ||
| Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat | Q77772586 | ||
| NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor | Q80382886 | ||
| The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury | Q80545779 | ||
| Neurotrophins: mediators and modulators of pain. | Q36507606 | ||
| Nerve growth factor: from the early discoveries to the potential clinical use | Q36526946 | ||
| BDNF but not NT-4 is required for normal flexion reflex plasticity and function | Q36540995 | ||
| Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in rats | Q36627244 | ||
| Protein kinases as potential targets for the treatment of pathological pain | Q36646044 | ||
| Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. | Q36724679 | ||
| Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats | Q36793984 | ||
| Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain | Q36912778 | ||
| Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity | Q36935698 | ||
| TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways | Q37041596 | ||
| The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity | Q37239320 | ||
| Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors | Q37258596 | ||
| TrkB signaling is required for both the induction and maintenance of tissue and nerve injury-induced persistent pain | Q37289615 | ||
| Involvement of TrkB- and p75(NTR)-signaling pathways in two contrasting forms of long-lasting synaptic plasticity | Q37293533 | ||
| The role of dorsal root ganglia activation and brain-derived neurotrophic factor in multiple sclerosis. | Q37294255 | ||
| Targeting nerve growth factor in pain: what is the therapeutic potential? | Q37322267 | ||
| Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states | Q37362605 | ||
| c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? | Q37412516 | ||
| Treadmill exercise reduces spinal cord injury-induced apoptosis by activating the PI3K/Akt pathway in rats | Q37574857 | ||
| Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models | Q37601317 | ||
| Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases | Q37894003 | ||
| The neurotrophin family of neurotrophic factors: an overview | Q37988419 | ||
| p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity | Q38002635 | ||
| Pro-neurotrophins, sortilin, and nociception | Q38185068 | ||
| Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions | Q38185071 | ||
| Neurotrophins in the regulation of cellular survival and death | Q38199413 | ||
| Mechanisms of disease: role of neurotrophins in diabetes and diabetic neuropathy | Q38269667 | ||
| Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? | Q38292331 | ||
| A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee | Q38295106 | ||
| Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods | Q39128725 | ||
| Selective induction of tyrosine hydroxylase and dopamine β-hydroxylase by nerve growth factor: comparison between adrenal medulla and sympathetic ganglia of adult and newborn rats | Q39164014 | ||
| Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain | Q39195605 | ||
| Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. | Q39289155 | ||
| Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance | Q39336890 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuralgia | Q1136940 |
| neuropathic pain | Q2798704 | ||
| nerve growth factors | Q98072643 | ||
| P304 | page(s) | 10657-10688 | |
| P577 | publication date | 2015-06-09 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Neurotrophins and Neuropathic Pain: Role in Pathobiology | |
| P478 | volume | 20 |
| Q64093272 | A Novel Peptide Interfering with proBDNF-Sortilin Interaction Alleviates Chronic Inflammatory Pain |
| Q37592861 | Activation of neurotrophins in lumbar dorsal root probably contributes to neuropathic pain after spinal nerve ligation. |
| Q38826512 | Alleviation of pain in painful diabetic neuropathy |
| Q52331711 | An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. |
| Q47994138 | An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain |
| Q47159630 | Attenuation of the Infiltration of Angiotensin II Expressing CD3+ T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia - A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT2) Recept |
| Q60915306 | Bogijetong Decoction and Its Selected Formulation Are Involved in Alleviating Neuropathic Pain in a Rat Model of Chronic Constrictive Injury |
| Q45992958 | Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms. |
| Q68691896 | CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain |
| Q91710271 | Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy |
| Q48232122 | Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models. |
| Q90575393 | Dim Light at Night Exposure Induces Cold Hyperalgesia and Mechanical Allodynia in Male Mice |
| Q58741796 | Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush |
| Q33705029 | Impaired Spinal Glucocorticoid Receptor Signaling Contributes to the Attenuating Effect of Depression on Mechanical Allodynia and Thermal Hyperalgesia in Rats with Neuropathic Pain |
| Q88753838 | Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity |
| Q37701087 | Macrophage and nerve interaction in endometriosis |
| Q54981810 | Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors. |
| Q55005540 | Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update. |
| Q94338265 | Nerve growth factor for neuropathic pain |
| Q90258507 | Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia |
| Q37256159 | Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity |
| Q57022000 | Neuron activity-induced Wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit |
| Q92328941 | Neurotrophins and neuropathic pain in patients with traumatic brain injury |
| Q59126105 | Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model |
| Q93042699 | Panax ginseng (Korea Red Ginseng) repairs diabetic sensorineural damage through promotion of the nerve growth factor pathway in diabetic zebrafish |
| Q33802464 | Peripheral inflammatory pain sensitisation is independent of mast cell activation in male mice |
| Q58694734 | Peripheral sympathetic mechanisms in orofacial pain |
| Q52663819 | Physiologic facet capsule stretch can induce pain & upregulate matrix metalloproteinase-3 in the dorsal root ganglia when preceded by a physiological mechanical or nonpainful chemical exposure. |
| Q89449289 | Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model |
| Q47985898 | Role of the spinal TrkB-NMDA receptor link in the BDNF-induced long-lasting mechanical hyperalgesia in the rat: A behavioural study |
| Q35884375 | SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy |
| Q38605796 | Swimming Training Reduces Neuroma Pain by Regulating Neurotrophins |
| Q52669750 | Systemic Inflammation Inhibits Serotonin Receptor 2-induced Phrenic Motor Facilitation Upstream from BDNF/TrkB Signaling. |
| Q33668659 | Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain |
| Q36792598 | The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity. |
| Q97075152 | The Delayed-Onset Mechanical Pain Behavior Induced by Infant Peripheral Nerve Injury Is Accompanied by Sympathetic Sprouting in the Dorsal Root Ganglion |
| Q59519802 | Ultraschallgesteuerte Interventionen am peripheren Nervensystem |
| Q38660842 | Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis. |
| Q59792715 | Villainous role of estrogen in macrophage-nerve interaction in endometriosis |
| Q47877991 | WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms |
Search more.